Wendy’s CFO, Kerrii Anderson, gets top job

Wendy’s International, Inc. has announced that its Board of Directors has named Kerrii Anderson as Chief Executive Officer and President of the Company. The decision by the Board was unanimous.

Anderson, 49, was interim CEO and President since April 2006, and was previously Chief Financial Officer. Anderson is also a member of the Board of Directors.

“Following a national search over the past six months, we have decided that Kerrii is our best choice for CEO,” said Chairman Jim Pickett. “Kerrii has demonstrated excellent leadership skills. As interim CEO, she began a transformation of the Company, improved Wendy’s performance, developed a new strategic plan and executed several transactions that will continue to create value for shareholders. The Board knows that Kerrii has a passion for the Wendy’s business. She is committed to building strong relationships with our franchisees, and has the respect and support of Wendy’s management team. Our entire Board supports Kerrii, and we look forward to working with her in the future.”

Anderson joined Wendy’s in September 2000 as Executive Vice President and CFO, and was appointed to the Board in November 2000. In addition to her accounting and finance responsibilities, she has managed key areas of the corporation, including Strategic Planning, Human Resources, Supply Chain, Information Technology and Wendy’s bakery.

Prior to joining Wendy’s, Anderson was Senior Vice President and Chief Financial Officer of M/I Schottenstein Homes, Inc. for 14 years. M/I is a $1 billion NYSE-listed company that is one of the nation’s leading homebuilders. She was also on the Board of Directors of M/I.

Anderson has an MBA from the Fuqua School of Business at Duke University and a Bachelor of Arts degree in business administration from Elon University in North Carolina. Anderson has served on the finance committee of the Columbus Foundation, the OhioHealth finance committee and on several other boards.

She is currently on the board of LabCorp (Laboratory Corporation of America Holdings), a NYSE-listed company that is one of the world’s largest clinical laboratories, with annual revenues of $3.3 billion.